|
Emami buys out Vaidyas in Zandu Pharma
2008-06-02 08:16:00 Emami Ltd on Friday bought out the entire stake of the Vaidya family, one of the two promoter groups, in Zandu Pharmaceutical Works Ltd. ... Click on Headline to read full Article..
Emami buys out Vaidyas in Zandu Pharma
2008-06-02 08:16:00 Emami Ltd on Friday bought out the entire stake of the Vaidya family, one of the two promoter groups, in Zandu Pharmaceutical Works Ltd. ... Click on Headline to read full Article..
Bafna Pharma IPO Allotment status and Allocation
2008-06-01 09:07:00 Bafna Pharma IPO Allotment status and allocation details will be updated here. Click here to see the allotment details of bafna pharma IPO
Some BIG PHARMA Facts. . .
2008-05-29 18:09:00 With dems (notably Obama) constantly declaring war on every major business that make our lives better I think it's appropriate to debunk some of dems attacks on our pharmaceutical industry: Time to develop and market a new drug: 10-15 years Average Cost to develop a new drug (2006): $1.318 billion Total R&D spending on drugs in 2007: $58.8 billion Generic share of market in 2007:... Click the Headline Link to Visit Copious Dissent and Read the Full Story.
Bafna Pharma IPO opens for subscription
2008-05-29 03:15:00 Bafna Pharmaceuticals will open for subscription today with its public issue of 64,00,000 equity shares of Rs 10 each at a price of Rs 40 per ... Click on Headline to read full Article..
Sun Pharma?s $454-Million Deal With Israel?s Taro Called Off
2008-05-28 18:03:00 It's not a done deal for Sun Pharmaceuticals. The Mumbai based pharma company's last year's $454 million deal to acquire Israel's Taro Pharmaceut10 Vote(s)
By: Market Buzz
Plethico Pharma Stock Split
2008-05-28 06:44:00 Plethico Pharmaceuticals Stock Split has been announced by the company. In an annoucment made the company has informed the BSE that the board at its meeting held on May 27 has recommended dividend...[[ This is a content summary only. Vi3 Vote(s)
By: Market Buzz
Pharma stocks regain investors' interest
2008-05-27 16:04:00 'Plenty of growth opportunities for generic cos' Mumbai, May 26 The market might be in a very volatile phase but the pharma stocks seem to be quite fortified from the market volati6 Vote(s)
By: Market Buzz
CROS ARE DE FACTO WAY FOR PHARMA OUTSOURCING
2008-05-24 08:55:00 As drug companies lose patent protections, they are laying of thousands of employees across the world. Contract research organizations (CRO) saw possibilities in the trend. The numbers of such firms- who handle research or clinical trial for pharma and biotech companies – have thus substantially increased nationally, especially in Massachusetts. The trend is not new, it has been around for years, it's only recently got momentum.CRO contracts range from under $100 for a simple analysis to millions of dollars over a couple of years for management of a clinical trial, through either a flat or monthly fee, depending on the client.Biotechnology startups are also relying more on CROs to stretch valuable venture capital cashRead Three years ago someone suggested not calling it outsourcing. Call it partnership or strategic sourcing.Things have changed since then a lot. Don't have time to visit the blog often? Let me send you outsourcing news, views, career tips, ana...
Tonira Pharma
2008-05-23 11:15:00 Tonira Pharma has got US FDA approval for its manufacturing facility located in vadodara. Company can now concentrate on Export Market now. Anyone... Click on Headline to read full Article..
Bafna Pharma IPO
2008-05-20 13:16:00 Bafna Pharma IPO opens on May 27 Price per share 40.Rs addthis_url = 'http%3A%2F%2Fbirlaa.com%2F2008-%2F05%2F20%2Fbafna-pharma-ipo-2-%2F'; ... Click on Headline to read full Article..
Sun Pharma Advanced Research Company
2008-05-20 08:02:00 Buy Sun Pharma Advanced Research Company Stop loss of Rs 88 Target of Rs 1232 Vote(s)
By: Market Buzz
BAFNA Pharma IPO Subscription Date
2008-05-18 21:16:00 Bafna Pharmaceuticals IPO is scheduled to open for subscription on May 27, 2008. It is a fixed price IPO. IPO price has been fixed at Rs. 40 per share of face value Rs. 10 each. The public issue opens for subscription on Tuesday, May 27, 2008 and will close for subscription on May 30, 2008. ...
PHARMA GAINS FROM DIABETES
2008-05-15 12:11:00 Source: Times of India 6th May?08, (Tuesday)Mumbai: Diabetes, Cardiac and gastrointestinal hold sway in India, where chronic therapies comprise more than 40% of the entire market. Like developed markets, India is gradually shifting to lifestyle disorders. And drug companies are profiting form diabetes and cardiovascular cases.The over searching trend of lifestyle diseases is dictating the fortunes of various therapeutic categories. Prescriptions for diabetes have grown over 15% compounded since 2000 in urban India. With India poised to have the largest number diabetics in future, the antidiabetic therapeutic area has had the highest growth rate of 26.1%, followed by cardiology at 21.3% and gynaecology at 18.3%, according to ORG-IMS data. The antidiabetic segment has grown from 19.5 %( MAT December 2006) to 26.1%(MAT December 2007). The gynaecology segment too recorded growth from 15.9% to 18.3% m during the same period.Not only are drug majors benefiting from the growing cases of di...
PHARMA GAINS FROM DIABETES
2008-05-15 12:10:00 Source: Times of India 6th May?08, (Tuesday)Mumbai: Diabetes, Cardiac and gastrointestinal hold sway in India, where chronic therapies comprise more than 40% of the entire market. Like developed markets, India is gradually shifting to lifestyle disorders. And drug companies are profiting form diabetes and cardiovascular cases.The over searching trend of lifestyle diseases is dictating the fortunes of various therapeutic categories. Prescriptions for diabetes have grown over 15% compounded since 2000 in urban India. With India poised to have the largest number diabetics in future, the antidiabetic therapeutic area has had the highest growth rate of 26.1%, followed by cardiology at 21.3% and gynaecology at 18.3%, according to ORG-IMS data. The antidiabetic segment has grown from 19.5 %( MAT December 2006) to 26.1%(MAT December 2007). The gynaecology segment too recorded growth from 15.9% to 18.3% m during the same period.Not only are drug majors benefiting from the growing cases of di...
Aventis Pharma launches SoloStar in India
2008-05-14 05:25:00 Aventis Pharma Limited, a Sanofi-Aventis group company, has launched a new prefilled disposable insulin pen SoloStar for use with the 24-hour insulin Lantus."The insulin market in India is about Rs 410 crore and we have captured a market of about 7% with Lantus. The launch of SoloStar will boost our market share by another 1-2%," said Susheel Umesh, senior director, Cardio-Metabolism Business Unit who was in Ahmedabad for the launch. The Chicago Athenaeum Museum of Architecture and Design awarded the 2007 Good Design award to SoloStar.Lantus has a global market of 2 billion Euros. SoloStar reduces the injection force by 30% or more in comparison to other leading disposable pens, he added.According to diabetologist Sanjeev Phatak after Tamil Nadu, Gujarat has highest prevalence of diabetes. "There would be 30-40 lakh diabetes patients in Gujarat of which about 4-5 lakh would be in Ahmedabad," Phatak said.Source: business-standard.com
Researchreports) Urgent Requierd Report on SMS Pharma
2008-05-09 16:45:00 Dear All Plz frwd any broking house report on SMS Pharma ITS URGENT
surya pharma
2008-05-04 06:42:00 invest here and now. worst is over for surya pharma Home About Us BSEAnnouncements Indices Public I-ssues Reverse Bookbuilding& Buyback Listing CorporateFilings BSE TrainingInstitute My BSE Top Gainers ...
Various non academic jobs at GNDU Amritsar
2008-04-27 15:02:00 Name and Address of Company: GURU NANAK DEV UNIVERSITY (GNDU), AMRITSAR (Established by the State Legislature Act No.21 of 1969) GT Road, Amritsar, Punjab India Advertisement No. 3/2008 Applications are invited for the following posts on the prescribed application form so as to reach this office latest by 21.05.2008. 1. Divisional Accountant : 01 post (on contractual basis initially for ...
Jobs at UPSC Advt. No. 08/2008
2008-04-26 13:12:00 Name and Address of Company: Union Public Service Commission (UPSC) UPSC invites application on prescribed forms by 15th May 2008 (22nd May 2008 for the candidates from far flung areas) for various posts in various Government of India Ministries and Departments in the prescribed format. The post are : 1. One Professor (English) in National Defence Academy, Khadakwasla, ...
Troikaa Pharma plans EoU in A`bad
2008-04-25 05:09:00 Setting its sights on becoming a Rs 500-crore turnover company by 2012, Ahmedabad-based Troikaa Pharma is set to strengthen its focus on export markets.The company is planning to set up an export-oriented unit (EoU) at Sanand near Ahmedabad to manufacture critical care injectables, tablets and topical preparations. Its current facility in Dehra Dun will also see expansion this year.The new unit at Sanand will come up over an area of 75 acres for which land has already been acquired. The plant would being operations from from February 2009. Close to Rs 120 crore will be invested in the new unit, which will funded through internal accruals.?Exports form nearly 60 percent of our revenues. We are looking at newer export markets like Brazil, Mexico, South Africa, Columbia, Thailand and Phillipines,? said Ketan Patel, MD of Troikaa Pharma.The company is expecting a 40 per cent push to its topline and bottomline in the coming years on account of exports. The turnover for the year 2007-2008...
Big Pharma Uses Direct Tactics to Beat Parallel Traders
2008-04-22 17:19:00 Parallel traders are the thorn in the side for pharmaceutical companies operating in Europe. Local sales mangers see their bottom line eroded as independent exporters undercut them with their own product! The considerable efforts that pharma companies have gone to prevent this grey trade have largely failed. The majority of legal actions against traders ...
Dabur Pharma: Is it undervalued?
2008-04-22 00:02:00 By Priya Nigam?Consolidation? has been the name of the game across the world this year. The news so far in 2008 has been dotted by mergers and acquisitions. Despite the US credit crisis and the tight global financial situation, the value of M&A deals this year has surged passed the $1 trillion mark. Closer to home, however, the story has been different. In India, the value of M&A deals has plummeted almost 72% year-on-year. This is notwithstanding Tata Motors Ltd?s offer to take over Jaguar and Land Rover from Ford Motor Co.Another interesting deal in the Indian market involves the offer to buy a 73.3% control of oncology major Dabur Pharma. The company has announced that its promoters (the Burman family) and certain other stockholders have agreed to sell their shares to Singapore-based Fresenius Kabi Pte Ltd for Rs76.50 per share. Fresenius Kabi is a 100% subsidiary of the $12 billion German healthcare group Fresenius SE. The deal, which costs the global giant Rs878.2 crore...
By: The India Street
Pharma Vacancies
2008-04-21 13:45:00 Kami mengundang kandidat fresh graduate ataupun berpengalaman untuk beberapaposisi di perusahaan kami:1. Pharmacist- Untuk ditempatkan di bagian produksi atau di packaging- Telah mengikuti program profesi apoteker2. Engineering Staff- minimal D3 Teknik Mesin atau Elektro3. Asisten Apoteker- lulus dari Sekolah Menengah Farmasi (SMF) atau D3 FarmasiKirimkan CV Anda keAndreas.purnawan@darya-varia.-com
By: lowongan kerja
Ankur Drugs And Pharma Limited
2008-04-14 09:52:00 Free Intraday Tips for 15th April 08SASKEN ( Sasken Communication Technologies Ltd) ActionTrigger Price Stop LossTarget 1 Target 2BUY ABOVE138135144153S.SELL BELOW132136127118Click here for more recommendations of stocks below Rs.150 ANKURDRUGS ( Ankur Drugs And Pharma Limited) ActionTrigger Price Stop LossTarget 1 Target 2BUY ABOVE210204219229S.SELL BELOW201206195178SELAN ( Selan Exploration Technology Ltd) ActionTrigger Price Stop LossTarget 1Target 2BUY ABOVE188182198210S.SELL BELOW179183171153Read more... Did You Enjoy this Post?Subscribe Today. Click here for more recommendations of stocks below Rs.150 Click here to Get Tips for your own Stocks
Code of Conduct for pharma industry bars ‘exotic’ offers for doctors
2008-04-12 19:04:00 By Bandula SirimannaThe newly amended Code of Marketing Pharmaceutical Practices has laid down strict guidelines preventing the offering or providing of any favours including foreign trips for medical practitioners in return for prescribing drugs.The pharmaceutical industry which had come under some criticism in the recent past for alleged unethical marketing practices has laid down in its Code with some strong restrictions for its members which include linking sponsorships to International /Local medical Congresses, to any obligation to prescribe, recommend or promote any pharmaceutical product.The Sri Lanka Chamber for Pharmaceutical Industry (SLCPI) Code also specifically prohibits members from organising any social events for doctors and clearly states that any sponsorship which involves symposiums or professional meetings should be purely to inform about healthcare products or provide scientific or educational information that would benefit the healthcare professionals and the ...
EXCISE ON PHARMA; LOAD ON CONSUMER
2008-03-22 08:02:00 In a first-of-its-kind move, the drug price regulator asked pharmaceutical companies to pass on the benefit of the recent excise duty cut to consumers even on medicines that are outside government’s price control. This will reduce prices by 4.58% on brands that account for three fourth of the Rs 33,000-crore domestic pharmaceutical market. While intervening in the control-free segment of the market for the first time to emphasise that excise cut benefit should be passed on to consumers, the price regulator said emphatically that companies “must” reduce prices. The regulator also said it will use a public interest clause in the drug pricing law to enforce Monday’s order. Finance minister P Chidambaram had halved the excise duty on all medicines from 16 % to 8 % in this year’s budget. Excise duty will now be levied on 64.5% of the MRP instead of 57.5% earlier. This works out to a 4.58% cut in the MRP on all medicines. Drug makers have to s...
By: India Blog
DHG Pharma to buy back stock
2008-03-20 05:20:00 DHG Pharmaceutical Joint ? Stock Company (DHG Pharma) will repurchase its shares as follows: Stock symbol: DHG Number of treasury shares before trading: 2,280 shares Number of shares registered to buy back: 490 shares Number of treasury shares after trading: 2,770 shares Purpose: to buy back the preferred shares... [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Despite Challenges- Big Pharma Companies Turn Attention to Emerging Markets
2008-03-19 16:41:00 Faced with dwindling growth rates in the US and Europe, pharmaceutical companies are turning their attention towards emerging pharmaceutical markets whose double-digit growth is fuelled by their recent economic booms. However, although the patient potential of the emerging market countries is enormous, foreign pharma companies are currently tapping into only a fraction of the consumers, ...
Teva to expand pharma plant - Prague Post
2008-03-13 19:36:00 Teva to expand pharma plantPrague Post, Czech Republic - 5 hours ...
By: Israel-Times.com
Reliance plans pharma unit in Jamnagar
2008-03-07 01:21:00 While company executives refused to divulge further details, industry sources said that Reliance has earmarked a huge area in the SEZ for the project.9 Vote(s)
By: Market Buzz
Sciele Pharma And Plethora Solutions Holdings PLC Announce Initiation Of Pi
2008-03-07 01:02:00 The service of PSD502 in the service of the treatment of untimely ejaculation.May 2007, Sciele signed an licensing concord in the service of PSD502 with Plethora Solutions.PSD502 is a proprietary formulation of two marketed drugs - lidocaine and prilocaine - dispensed by a metered administer aerosol and developed in the service of the treatment of untimely ejaculation, a disorder affecting up to 30% of men in Europe and the U.And in the service of which there currently is no FDA-approved medication treatment.Offering is applied locally when needed ( continually referred to as "on demand" therapy) and is serviceable within five minutes.Offering has been shown to dilate ejaculation latency duration whenpared with placebo in a multi-center wind up II investigation This figures was published recently in BJU universal _(Dinsmore W et al 2007, BJU Int 99: 369-35)_.Patrick Fourteau, President and Chief director copper of Sciele Pharma, said, "We are tickled pink with the capital at work Pl...
By: medicine news
Quotes from Bio-Pharma Development Summit
2008-02-27 10:28:00 ?Today, companies have to realise that it?s not only about competing, but also about co-operating.? ? Malvinder Singh, MD & CEO, Ranbaxy Laboratories?The challenge in R&D is to keep people going on a project for 10 years and deciding if bonus is to be paid if it fails.? ? Shiv Raman Dugal, Chairman, ICRI?India?s current challenge in healthcare and research and development will be its future strength? ? Ted Bianco, Director, Wellcome Trust?We came to India looking for cheap hands, but after three years, we realise that we are staying here for the brains.? ? Dr. Naveen Rao, Managing Director, Merck & Co, India?Incremental research, reverse pharmacology and research in herbal products offer attractive opportunities? ? Pratibha Pilgaonkar, CEO, Rubicon Research?We have a drug offering a real possibility of eradicating Kala Azar, through public-private partnership? ? Kavita Khanna, President, Bharat Serums & Vaccines?India offers a fast track alternative to clinical R&...
BHEL, Tata Steel, Bharat Electronics, Central Bank, Dish TV, Dishman Pharma
2008-01-29 04:26:00 BHEL, Tata Steel, Bharat Electronics, Central Bank, Dish TV, Dishman Pharma, Jyoti Structures, Suzlon Energy, India Economy advertising [[ This is a content summary only. Visit my website for full links, other content, and more! ]]
Need For Drug Detox Will Increase In Spite Of Big Pharma Cut-Backs
2008-01-28 21:01:00 Prescription drug detox numbers may likely grow as generic drugs replace brands. With 40,000 jobs lost and more cut-backs expected, Big Pharma is shrinking. But before you breathe a sigh of relief, the industry wide reductions occurring among most Big Pharma corporations will probably create even more of a need, not less, for prescription ...
Adult and Pharma Bloging
2008-01-22 19:20:00 ? ?????, ??? ? ??????????? ???, ????? ??????? ??? ?????. ???, ?? ?????? ??? ? ???? ??????, ? ????? ????????? ???? ???????? ????, ??? ? ?????? ??????. ? ????? ? ?????????? ?????????? ????????, ?? ? ?? ???? ????? ? ???. ?? ???? ?? ?????, ????? ? ????????? ??? ? ?? ??????? ?????, ??????? ??????, ? ...
Noven Pharma Gets FDA Warning Letter (AP via Yahoo! Finance)
2008-01-11 00:00:00 Noven Pharmaceuticals Inc., which makes skin patches for drug delivery, said Thursday it received a warning letter from the Food and Drug Administration related to a mid-2007 Miami facility inspection.
Noven Pharma Gets FDA Warning Letter
2008-01-11 00:00:00 Noven Pharmaceuticals Inc., which makes skin patches for drug delivery, said Thursday it received a warning letter from the Food and Drug Administration related to a mid-2007 Miami facility inspection.
PARTY FOR PHARMA STOCKS TO START
2008-01-09 11:40:00 Pankajji, what about Aventis Pharma? Looks good considering 52Wk High/Low data but volume is very less.. your advice is appreciated… On Jan 9, 2008 2:15 PM, hariom vimla wrote: > pankaj ji please help me with dabur pharma. i have added at 86 levels. > shld i sell or hold > > On Jan 9, 2008 ...
Big Pharma Spends More On Advertising Than Research And Development, Study
2008-01-08 17:16:00 Wow, just think about this: ScienceDaily (Jan. 7, 2008) ? A new study by two York University researchers estimates the U.S. pharmaceutical industry spends almost twice as much on promotion as it does on research and development, contrary to the industry?s claim. The researchers? estimate is based on the systematic collection of data directly from the industry ...
Roundup: Super Ministries, LBC Co-Dependence, Pharma Outsourcing, and 40 Ho
2008-01-06 20:10:00 With so much going on in China, and only a limited amount of bandwidth, I have created this weekly post to highlight articles that I feel are (1) important, (2) relevant, and (3) interesting. This week there are 5 articles that I have put into the mix, and the breadth of these articles covers Central party ... SHARETHIS.addEntry({ title: "Roundup: Super Ministries, LBC Co-Dependence, Pharma Outsourcing, and 40 Hour Laptop Batteries", url: "http://www.allroadsleadtochina-.com/index.php/2008/01/06/chine-se-scientist-develops-40-hour-l-aptop-battery/" });
Dabur Pharma: Trading call
2008-01-06 18:30:00 Hi A new trading call for you savy stock investors. Dabur Pharma The Stock closed at 84.20 on Friday January 4th. It touched a 52 week high of 92.4 on 3rd January. Profit booking might have brought the stock down. Technically it had a breakout over 86-87. For more than a year it tested these levels but went down from there. In this January rally it might go above this level and trade above it for quite some time. Tomorrow that is Monday January 7th,2008 we will see a sharp cut in the market because of weak US Job data numbers and the fall in US markets. This will give us a good level to enter in this stock. Try to get into this stock around 80-84 levels with a price target of 95+ this means a gain of around 15%+ in the next 15 trading sessions. Hold the stock even when the target is achieved. A new target will be published after 95 is crossed. All Loss should be booked if it goes below the Stop Loss level of 75. Summary Buy: 80 - 84 Target 1: 95+ Target 2: Visit after T1 i...
Parsvnath Developers to set up Pharma SEZ in Nanded, Maharashtra | INRnews
2008-01-03 13:47:00 New Delhi, India, January 03, 2007 Parsvnath Developers Ltd has announced that in pursuance to development of SEZs, Parsvnath SEZ Ltd (PSL), a subsidiary of the Company, will develop a Pharmaceutical Special Economic Zone (SEZ) at Nanded in Maharashtra. The Company has received LoI from Maharashtra Industrial Development Corporation (MIDC), a Maharashtra Govt. Undertaking for development of Pharma SEZ project in krushnoor Industrial Area of Nanded which is in close proximity to the SH-6 connecting Nanded and Secunderabad.
PARTY FOR PHARMA STOCKS TO START
2008-01-02 15:42:00 after consolidating for few days pharma stocks have given good move today. seems we will see good move in coming days in pharma stocks. cipla and biocon has given good break outs today.ranbaxy is just on verge of break out and ready to explode. Pankaj shah On Dec 19 2007, 9:14 pm, pankaj564 wrote: > ...
Pharma Management Software
2007-12-26 08:47:00 Monark Pharma Expert - A Complete Software Solution As per GMP(Schedule'M'), WHO, ISO - 9001Applicability: Allopathic, Ayurvedic, Homeopathic, Pharmaceuticals, Surgical, Analytical Labs, food Processing and Chemical IndustriesMonark System Information Technology is a joint venture of young and innovative software engineers. Features of Pharma Expert : 1. Financial Accounting Management2. Financial Reports3. Marketing Management4. Forms & Excise Reports5. Inventory Management & production planning6. Q.C. and Q.AContact Address:MONARKSystem Information TechnologyKanpur office : 460,Mangla Vihar - 1, Chakeri, kanpur - 208 015Mob : 09415041771 , Ph : 0512 - 2421713New Delhi Office : D1/62 -B, Sitapuri, part - 1, dabri Mod, Janakpuri, New DelhiMob : 09899181416, 09811328244, Ph : 011 - 55185836Email : info@monarksystem.comWebsite : www.monarksystem.comFor career enhancement programs in emerging life science, pharma and chemical science areas visit www.bii.in/biodlp
NATCO PHARMA
2007-12-25 16:43:00 Dear Venky: This stock has indeed been under accumulation mode for the past couple of months. There has been a huge surge in the trading volumes of the stock in the last 3 trading sessions. There is good fundamental story unfolding here & the real upside here is unclocking of land value worth Rs 375 Crs = ...
PARTY FOR PHARMA STOCKS TO START
2007-12-19 17:41:00 sir you are a technichal and breakout expert so you know when to enter and exit a stock but we look at the stock that are at their lowest we think in this rising market only those stock can help us to remain in this market as we dont have guts to buy reliance etc ...
PARTY FOR PHARMA STOCKS TO START
2007-12-13 12:41:00 friends did u joined party today or not?mkt was dn by 300 points and no of pharma stocks up by 5 to 10 % Pankaj Shah On Dec 12, 4:19 pm, pankaj564 wrote: > friends > recently i have been recommending pharma stocks as defensive bets and > being laggard stocks this yr. > ... |
|
 |
|
 |
